HALISTER: Sanofi’s Lyxumia No Worse Than Placebo for Heart Safety: Study

Sanofi’s Lyxumia No Worse Than Placebo for Heart Safety: Study

Alert: HALISTER Source: BFW (Bloomberg First Word)

Tickers SAN FP (Sanofi) ZEAL DC (Zealand Pharma A/S) LLY US (Eli Lilly & Co) NOVOB DC (Novo Nordisk A/S)

Topics Diabetes Heart Disease

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283